TearScience

Last updated

TearScience is an American company founded in 2005 that develops, manufactures and markets ophthalmic medical devices aiding in the identification and treatment of meibomian gland dysfunction, which can lead to dry eye disease, [1] which is a condition that affect as many as 25 million Americans. The company's Lipiflow System was FDA cleared in June 2011 for treating meibomian gland dysfunction [2] and is currently installed in over 250 locations across the globe. The company is headquartered in Morrisville, North Carolina.

Contents

Products

LipiView Ocular Surface uses interferometry to measure the thickness of the tear film oily lipid layer. [3] LipiFlow Thermal Pulsation System uses heat and pressure to unblock obstructed meibomian glands [4] to reduce dry eye symptoms. [5]

Related Research Articles

Tears Clear liquid secreted from glands in eyes of mammals

Tears are a clear liquid secreted by the lacrimal glands found in the eyes of all land mammals. Their functions include lubricating the eyes, removing irritants, and aiding the immune system. Tears also occur as a part of the body's natural pain response. Humans are the only mammals known to produce tears as part of an emotional response, such as out of joy or grief. Tears have symbolic significance among humans. Emotional secretion of tears may serve a biological function by excreting stress-inducing hormones built up through times of emotional distress. Tears are made up of water, electrolytes, proteins, lipids, and mucins that form layers on the surface of eyes. The different types of tears—basal, reflex, and emotional—vary significantly in composition.

Isotretinoin Medication primarily used to treat severe acne

Isotretinoin, also known as 13-cis-retinoic acid and sold under the brand name Accutane among others, is a medication primarily used to treat severe acne. It is also used to prevent certain skin cancers, and in the treatment of other cancers. It is used to treat harlequin-type ichthyosis, a usually lethal skin disease, and lamellar ichthyosis. It is a retinoid, meaning it is related to vitamin A, and is found in small quantities naturally in the body. Its isomer, tretinoin, is also an acne drug.

Intense pulsed light (IPL) is a technology used by cosmetic and medical practitioners to perform various skin treatments for aesthetic and therapeutic purposes, including hair removal, photorejuvenation as well as to alleviate dermatologic diseases such as acne. IPL is increasingly used in optometry and ophthalmology as well, to treat evaporative dry eye disease due to meibomian gland dysfunction.

LASIK Corrective ophthalmological surgery

LASIK or Lasik, commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and an actual cure for astigmatism, since it is in cornea. LASIK surgery is performed by an ophthalmologist who uses a laser or microkeratome to reshape the eye's cornea in order to improve visual acuity. For most people, LASIK provides a long-lasting alternative to eyeglasses or contact lenses.

Blepharitis Medical condition

Blepharitis is one of the most common ocular conditions characterized by inflammation, scaling, reddening, and crusting of the eyelid. This condition may also cause burning, itching, or a grainy sensation when introducing foreign objects or substances to the eye. Although blepharitis is not sight-threatening, it can lead to permanent alterations of the eyelid margin. The overall etiology is a result of bacteria and inflammation from congested meibomian oil glands at the base of each eyelash. Other conditions may give rise to blepharitis, whether they be infectious or noninfectious, including, but not limited to, bacterial infections or allergies.

Dry eye syndrome Medical condition

Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. Symptoms range from mild and occasional to severe and continuous. Scarring of the cornea may occur in untreated cases.

Human eye Mammalian eye; part of the visual organ of the human body, and move using a system of six muscles

The human eye is a sense organ that reacts to light and allows vision. Rod and cone cells in the retina are photoreceptive cells which are able to detect visible light and convey this information to the brain. Eyes signal information which is used by the brain to elicit the perception of colour, shape, depth, movement, and other features. The eye is part of the sensory nervous system.

Meibomian gland Exocrine glands, along the rims of the eyelid

Meibomian glands are holocrine type exocrine glands, along the rims of the eyelid inside the tarsal plate. They produce meibum, an oily substance that prevents evaporation of the eye's tear film. Meibum prevents tears from spilling onto the cheek, traps them between the oiled edge and the eyeball, and makes the closed lids airtight. There are about 25 such glands on the upper eyelid, and 20 on the lower eyelid.

Artificial tears

Artificial tears are lubricating eye drops used to relieve dryness and irritation of the ocular surface. Dry eye syndrome is a common ocular surface disorder and is characterized by disruption of the tear film and increased inflammation.

Ocular tonometry

Tonometry is the procedure eye care professionals perform to determine the intraocular pressure (IOP), the fluid pressure inside the eye. It is an important test in the evaluation of patients at risk from glaucoma. Most tonometers are calibrated to measure pressure in millimeters of mercury (mmHg).

Lacritin

Lacritin is a 12.3 kDa glycoprotein encoded in humans by the LACRT gene. Lacritin's discovery emerged from a screen for factors that stimulate tear protein secretion. Lacritin is a secreted protein found in tears and saliva. Lacritin also promotes tear secretion, the proliferation and survival of epithelial cells, and corneal wound healing Lacritin is thus a multifunctional prosecretory mitogen with cell survival activity. Natural or bacterial cleavage of lacritin releases a C-terminal fragment that is bactericidal.

Besifloxacin

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003.

Conjunctivochalasis Medical condition

Conjunctivochalasis is a common eye surface condition characterized by the presence of excess folds of the conjunctiva located between the globe of the eye and the eyelid margin.

Gerd Geerling is a German consultant ophthalmic surgeon, Professor of Ophthalmology and since 2011 head of the Universitäts-Augenklinik Düsseldorf of the University of Düsseldorf, Germany.

Meibomian gland dysfunction

Meibomian gland dysfunction is a chronic disease of the meibomian glands, which is commonly characterized by obstruction of the end of the duct that delivers the secretion produced by the glands to the eye surface, which prevents the glandular secretion to reach the ocular surface. The dysfunction could be that amount of secretion produced may be abnormal. Dysfunction could also be related to the quality of the meibum produced. MGD may result in evaporative dre eye, blepharitis, chalazion, unsealed lid during sleep, and meibomian gland atrophy.

Lifitegrast

Lifitegrast, sold under the brand name Xiidra, is a medication for the treatment of signs and symptoms of dry eye, a syndrome called keratoconjunctivitis sicca. Lifitegrast reduces inflammation by inhibiting inflammatory cell binding. It is often used in conjunction with ciclosporin for dry eye treatment including meibomian gland dysfunction and inflammatory dry eye.

Tear break-up time (TBUT) also known as tear film break-up time (TFBUT) is the time taken to appear first dry spot on cornea after a complete blinking. TFBUT measurement is an easy and fast method used to assess the stability of tear film. It is a standard diagnostic procedure in the dry eye clinics. The volume of tear in the eye depends on two factors, drainage through the lacrimal passages and evaporation. Factors like decreased tear production, increased evaporation rate, tearfilm instability, tear hyperosmolarity, inflammations, ocular surface damages etc. can cause dryness to the eyes.

Exposure keratopathy is medical condition affecting the cornea of eyes. It can lead to corneal ulceration and permanent loss of vision due to corneal opacity.

Tear Film & Ocular Surface Society (TFOS) is a 501(c)(3) nonprofit organization founded in 2000 focused on facilitating consensus and standardization on ophthalmological research related to ocular surface subjects like tear film, dry eye, meibomian gland dysfunction and contact lens discomfort. TFOS organize workshops and produce reports which are then translated to different languages.

Evaporimetry is medical test to measure the rate of the evaporation of the eye. Individuals with meibomian gland dysfunction will have an increased rate of evaporation because the glands release lower quality meibum. This impacts the tear film increasing the evaporation rate and can cause dry eye. The device used to perform an evaporimetry is called evaporimeter.

References

  1. "Hawaiian Eye & Retina 2021 Meeting - Home". www.healio.com. Retrieved 2020-07-27.
  2. Lane SS, et al. (2012). "A new system, the LipiFlow, for the treatment of meibomian gland dysfunction". Cornea. 31 (4): 396–404. doi:10.1097/ico.0b013e318239aaea. PMID   22222996.
  3. Eom Y, Lee JS, Kang SY, Kim HM, Song JS (June 2013). "Correlation between quantitative measurements of tear film lipid layer thickness andmeibomian gland loss in patients with obstructive meibomian gland dysfunction and normal controls". American Journal of Ophthalmology. Epub 2013 Mar 7. 155 (6): 1104–1110. doi:10.1016/j.ajo.2013.01.008. PMID   23465270.
  4. Korb DR, Blackie CA (August 2010). "Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case report". Cornea. 29 (8): 930–933. doi:10.1097/ICO.0b013e3181ca36d6. PMID   20531168.
  5. Greiner JV. (April 2012). "A single LipiFlow® Thermal Pulsation System treatment improves meibomian glandfunction and reduces dry eye symptoms for 9 months". Current Eye Research. 37 (4): 272–278. doi:10.3109/02713683.2011.631721. PMID   22324772.